Loading…
Patrick A Mayes is EVP & Chief Scientific Officer at Incyte. OQRO lists 56 transactions filed with the SEC under this name, the latest on Aug 7, 2026, each linked to the official Form 4.
EVP & Chief Scientific Officer
Disclosures on record
56
Companies involved
1
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Stock since the trade -4.5% · S&P 500 +3.7% · to Oct 5
Incyte's & Chief Scientific Officer sold $1.75M of Incyte shares. Nobody planned it ahead of time.
Stock since the trade -4.5% · S&P 500 +3.7% · to Oct 5
Incyte's & Chief Scientific Officer sold $737K of Incyte shares. Nobody planned it ahead of time.
Stock since the trade -4.5% · S&P 500 +3.7% · to Oct 5
Incyte's & Chief Scientific Officer sold $637K of Incyte shares. Nobody planned it ahead of time.
Stock since the trade -4.5% · S&P 500 +3.7% · to Oct 5
Incyte's & Chief Scientific Officer sold $561K of Incyte shares. Nobody planned it ahead of time.
Stock since the trade -4.5% · S&P 500 +3.7% · to Oct 5
Incyte's & Chief Scientific Officer sold $342K of Incyte shares. Nobody planned it ahead of time.
Stock since the trade -4.5% · S&P 500 +3.7% · to Oct 5
Incyte's & Chief Scientific Officer sold $274K of Incyte shares. Nobody planned it ahead of time.
Stock since the trade -4.5% · S&P 500 +3.7% · to Oct 5
Incyte's & Chief Scientific Officer sold $261K of Incyte shares. Nobody planned it ahead of time.
Stock since the trade -4.5% · S&P 500 +3.7% · to Oct 5
Incyte's & Chief Scientific Officer sold $196K of Incyte shares. Nobody planned it ahead of time.
Stock since the trade -4.5% · S&P 500 +3.7% · to Oct 5
Incyte's & Chief Scientific Officer sold $196K of Incyte shares. Nobody planned it ahead of time.
Stock since the trade -4.5% · S&P 500 +3.7% · to Oct 5
Incyte's & Chief Scientific Officer sold $40K of Incyte shares. Nobody planned it ahead of time.
Stock since the trade -4.5% · S&P 500 +3.7% · to Oct 5
Incyte's & Chief Scientific Officer sold $10K of Incyte shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.